Astrazeneca Pharma India informs about press release

11 Mar 2024 Evaluate
Astrazeneca Pharma India has enclosed copy of press release in connection with a Distribution and Promotion Agreement entered into by the Company with Mankind Pharma for the distribution of budesonide and formoterol fumarate dihydrate (brand name Symbicort) in India. Further, details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 attached as Annexure - A, in this regard.

The above information is a part of company’s filings submitted to BSE. 

Astrazeneca Pharma I Share Price

5408.05 74.20 (1.39%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.